SCS SB 514 -- LABELING OF DRUGS AND DEVICES

SPONSOR:  Singleton (Hosmer)

COMMITTEE ACTION:  Voted "do pass by consent" by the Committee
on Children, Families and Health by a vote of 13 to 0.

This substitute requires manufacturers, packers, distributors,
and sellers of drugs and devices in Missouri to comply with the
current federal labeling requirements contained in the Federal
Food, Drug and Cosmetic Act and any federal regulations created
under the act.  Drugs and devices which contain labeling not in
compliance with the bill will be deemed misbranded.

The substitute repeals the current state standards for
considering a drug or device misbranded.

FISCAL NOTE:  No impact on state funds.

PROPONENTS:  Supporters say that drug manufacturers have to
label drugs according to federal laws, not state law.  The bill
would eliminate duplication between the federal and state laws
on the labeling of drugs and devices and would eliminate the
need to continuously revise the state law in order to comply
with federal law.

Testifying for the bill were Senator Singleton; and Department
of Health.

OPPONENTS:  There was no opposition voiced to the committee.

Joseph Deering, Legislative Analyst

Missouri House of Representatives
Last Updated November 26, 2001 at 11:47 am